Mammalian peptidoglycan recognition proteins (PGRPs), similar to antimicrobial lectins, bind the bacterial cell wall and kill bacteria through an unknown mechanism. We show that PGRPs enter the Gram-positive cell wall at the site of daughter cell separation during cell division. In Bacillus subtilis, PGRPs activate the CssR-CssS two-component system that detects and disposes of misfolded proteins that are usually exported out of bacterial cells. This activation results in membrane depolarization, cessation of intracellular peptidoglycan, protein, RNA and DNA synthesis, and production of hydroxyl radicals, which are responsible for bacterial death. PGRPs also bind the outer membrane of Escherichia coli and activate the functionally homologous CpxA-CpxR two-component system, which kills the bacteria. We exclude other potential bactericidal mechanisms, including inhibition of extracellular peptidoglycan synthesis, hydrolysis of peptidoglycan and membrane permeabilization. Thus, we reveal a previously unknown mechanism by which innate immunity proteins that bind the cell wall or outer membrane exploit the bacterial stress defense response to kill bacteria.
a r t i c l e s Multicellular eukaryotes have several mechanisms to kill bacteria, including oxidative killing by phagocytic cells, complement and antimicrobial peptides present in phagocytic cells, on body surfaces, secretions and tissue fluids. The mechanisms of killing by these antibacterial systems are well established. Eukaryotes also produce antibacterial proteins such as antibacterial lectins 1, 2 and PGRPs (also known as PGLYRPs) 3, 4 , but the mechanism of bacterial killing by these large proteins is completely unknown and is likely to be different than that of small antibacterial peptides 5 . We sought to determine the mechanism of bacterial killing by PGRPs.
PGRPs are conserved from insects to mammals, recognize bacterial peptidoglycan, and function in antibacterial immunity. Mammals have four PGRPs, PGLYRP-1, PGLYRP-2, PGLYRP-3 and PGLYRP-4 (initially named PGRP-S, PGRP-L, PGRP-Iα and PGRP-Iβ) 6, 7 . PGLYRP-1, PGLYRP-3 and PGLYRP-4 are all directly bactericidal [8] [9] [10] [11] [12] , whereas PGLYRP-2 is an N-acetylmuramoyl-l-alanine amidase that hydrolyzes peptidoglycan 13, 14 . PGLYRP-1 is found mainly in polymorphonuclear leukocyte granules, PGLYRP-3 and PGLYRP-4 are found in the skin, eyes, salivary glands, tongue, throat, esophagus, stomach and intestine, and PGLYRP-2 is expressed mainly in the liver and is secreted into blood 3, 4 .
Peptidoglycan is a polymer of β(1-4)-linked N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc), cross-linked by short peptides containing l-and d-amino acids. It is a unique component of the cell wall of virtually all bacteria and is essential for the structural integrity, growth and survival of bacteria. For this reason, peptidoglycan is also a frequent target of antibacterial products, such as antibiotics (produced by bacteria and fungi) or animal innate immunity proteins. In mammals, peptidoglycan is recognized by Nod-like receptors, PGRPs, CD14, Toll-like receptor-2, mannosebinding lectin, RegIIIγ C-type lectin and lysozyme 4 .
PGRPs are specific for the MurNAc-pentapeptide fragment of peptidoglycan 3, 4 . It has been hypothesized that PGRPs kill bacteria by inhibiting peptidoglycan synthesis at one of the two extracellular steps (transglycosylation and transpeptidation). This hypothesis was based on our previous observation that bactericidal PGRPs bind peptidoglycan but do not permeabilize cytoplasmic membranes 5, 10, 12 and on a structural analysis of binding of peptidoglycan fragments to PGRPs, which was thought to prevent formation of cross-links between peptidoglycan's peptide stems in the growing cell wall 15 .
Here we reveal a previously unknown mechanism of bacterial killing in which PGRPs bind the cell wall or outer membrane and activate bacterial protein-sensing two-component systems that kill bacteria by inducing an exaggerated stress response.
RESULTS

PGRPs inhibit an intracellular step in peptidoglycan synthesis
We first tested whether PGRPs inhibit peptidoglycan synthesis, because previous studies have predicted that PGRPs inhibit transpeptidation 10, 12, 15 . We followed the rate of total peptidoglycan biosynthesis in Staphylococcus aureus by measuring incorporation of 3 H-GlcNAc into the polymeric insoluble cell wall peptidoglycan. Peptidoglycan biosynthesis was rapidly and completely inhibited by PGLYRP-1, PGLYRP-3, PGLYRP-4 and a heterodimer of PGLYRP-3 and PGLYRP-4 (PGLYRP-3:4), as it also was by the known peptidoglycan synthesis inhibitors penicillin G, moenomycin and vancomycin, and also by magainin and lysostaphin ( Fig. 1a) . Magainin rapidly permeabilizes the cytoplasmic membrane and immediately stops all metabolic reactions in the cell 16, 17 , whereas lysostaphin rapidly hydrolyzes the pentaglycine bridge in S. aureus peptidoglycan, which causes osmotic lysis of bacteria and also stops all metabolic reactions. These results indicate that bactericidal PGRPs cause rapid inhibition of peptidoglycan synthesis.
We then tested whether PGRPs inhibit the two extracellular steps of peptidoglycan synthesis, transglycosylation and transpeptidation. Penicillin G, as expected, inhibited transpeptidation and induced a high degree of incorporation of 3 H-GlcNAc into newly synthesized secreted polymeric uncross-linked peptidoglycan, whereas PGRPs (at concentrations that were bactericidal and inhibited peptidoglycan synthesis), antibiotics that have other mechanisms of action and magainin and lysostaphin did not inhibit transpeptidation ( Fig. 1b) .
We then tested whether PGRPs inhibit transglycosylation, which precedes transpeptidation in peptidoglycan synthesis. As expected, vancomycin and moenomycin induced accumulation of 3 H-GlcNAc in the cell membrane lipid fraction containing lipid II in S. aureus (the membrane-bound undecaprenyl-phosphate-GlcNAc-MurNAcpeptide, Fig. 1c ). However, PGRPs, similar to the other antibiotics and magainin and lysostaphin did not induce accumulation of lipid II in the cell membrane ( Fig. 1c) . These results indicate that PGRPs do not inhibit transpeptidation and transglycosylation and thus must inhibit an earlier intracellular step in peptidoglycan synthesis.
PGRPs kill bacteria by localizing to cell separation sites
To selectively and directly inhibit an intracellular step in peptidoglycan synthesis, PGRPs would have to enter the cytoplasm. Therefore, we next determined the localization of PGRPs in bacterial cells. Alexa Fluor 594-labeled PGLYRP-4 exclusively localized at the sites of newly-formed daughter cell separation in B. subtilis (Fig. 1d) . Dual labeling clearly showed that PGLYRP-4 did not colocalize with BODIPY-FL-labeled vancomycin; the latter localized at the sites of new peptidoglycan synthesis, which is primarily at the synthesis of new septa ( Fig. 1d) . Cells that synthesized new septa and had not started to separate were labeled only with vancomycin and did not bind PGLYRP-4. We obtained similar results with S. aureus; BODIPY-FL-labeled vancomycin demarcated the sites of new septa synthesis, and Alexa Fluor 594-labeled PGLYRP-4 localized to cell separation sites, although because of the smaller size of S. aureus cells, their perpendicular formation of new septa and the tendency of S. aureus to grow in clusters, there was a smaller spatial separation of PGLYRP-4 and vancomycin ( Fig. 1d) . We obtained similar results in B. subtilis with unlabeled PGLYRP-1 and PGLYRP-4 detected with antibody to V5 tag and also in another unrelated Gram-positive bacterium, Listeria monocytogenes ( Fig. 1e and Supplementary Fig. 1a,b) . No a r t i c l e s Cell separation after cell division is carried out by dedicated peptidoglycan hydrolases, which in B. subtilis are LytE, LytF and CwlS 18 , whose expression is limited to the cell separation sites 19 . PGLYRP-1 and PGLYRP-4 completely co-localized with LytE and LytF ( Fig. 1e) , which further indicates the preferential localization of PGRPs to the cell separation sites.
To determine whether localization of PGRPs to cell separation sites is necessary for their bacterial killing, we tested PGRP-mediated killing of B. subtilis ∆lytE:∆lytF and ∆lytE:∆lytF:∆cwlS mutant cells 18 , which do not separate after cell division. Both ∆lytE:∆lytF and ∆lytE:∆lytF:∆cwlS mutant strains were less efficiently killed by PGLYRP-1 than the wild-type (WT) strain ( Fig. 1f) . These mutants also did not show specific staining with Alexa Fluor 594-labeled PGLYRP-4 ( Supplementary Fig. 2a,b) , suggesting that the cellseparating LytE and LytF enzymes are required for efficient PGRP binding to bacteria and bacterial killing. This effect is selective for LytE and LytF, because deficiency in two other peptidoglycan hydrolytic enzymes, LytC and LytD, which have different specificity and function as autolytic but not cell-separating enzymes [18] [19] [20] , had no effect on bacterial sensitivity to PGRP-induced killing (Supplementary Fig. 3 ).
Killing of ∆lytE:∆lytF and ∆lytE:∆lytF:∆cwlS mutant cells by other bactericidal agents (aminoglycoside antibiotics and pore-forming peptide magainin) was similar to the killing of WT bacteria ( Supplementary  Fig. 2c,d) . These results indicate that other mechanisms of bacterial killing that are not dependent on the entry of the killing compound through the cell separation site are intact in these mutants.
We detected neither PGLYRP-4 nor PGLYRP-1 intracellularly in B. subtilis, S. aureus and L. monocytogenes when we analyzed merged stacks or individual scans from confocal microscopy of bacteria stained with PGRPs ( Fig. 1d,e and Supplementary Fig. 1 ). Our results thus show that PGRPs do not enter the cytoplasm and stay in the cell separation sites bound to the cell wall in the vicinity of the cytoplasmic membrane. They also further support our biochemical data showing that PGRPs do not inhibit any of the extracellular steps in peptidoglycan synthesis (Fig. 1b,c) , because at the time the cells begin to separate peptidoglycan synthesis at the separation sites has been completed.
Thus, in Gram-positive bacteria PGRPs gain access to the inner cell wall and cell membrane at the sites of peptidoglycan hydrolysis where daughter cells separate and trigger their lethal effect from this extracellular site without entering the cytoplasm.
PGRPs inhibit protein, RNA and DNA synthesis
We next tested whether PGRPs cause a general inhibition of biosynthetic reactions in bacteria. PGLYRP-1, PGLYRP-3, PGLYRP-4 and PGLYRP-3:4 all rapidly and completely inhibited protein, RNA and DNA synthesis, as shown by the inhibition of incorporation of 35 S-methionine and 35 S-cysteine, 3 H-uridine and 3 H-thymidine into proteins, RNA and DNA, respectively ( Fig. 2a-c) , at the same concentrations and with the same kinetics as they inhibited peptidoglycan synthesis ( Fig. 1a) . Titrating the inhibitory concentrations of PGRPs from 25 to 300 µg ml −1 revealed the same minimal concentrations for bactericidal effect and inhibition of all four biosynthetic processes (peptidoglycan, protein, RNA and DNA; data not shown).
We found a similar rapid and complete inhibition of peptidoglycan, protein, RNA and DNA synthesis (Figs. 1a and 2a-c) with magainin (due to the loss of membrane integrity) and with lysostaphin (owing to the loss of peptidoglycan, which results in immediate osmotic lysis). To differentiate between effects due to osmotic lysis from the loss of peptidoglycan integrity and effects due to membrane permeabilization, we performed similar experiments on inhibition of peptidoglycan, protein, RNA and DNA synthesis in hyperosmotic medium (with 0.5 M sucrose), which prevents osmotic lysis after the loss of peptidoglycan integrity but has no effect on the consequences of membrane permeabilization. As expected, 0.5 M sucrose prevented lysostaphin-mediated but not magainin-induced inhibition of protein, RNA and DNA synthesis, confirming that the inhibitory effect of lysostaphin is due to osmotic lysis of bacteria ( Fig. 2a-c) . Inhibition of protein, RNA and DNA synthesis by PGLYRP-1, PGLYRP-3, PGLYRP-4 and PGLYRP-3:4 was not prevented in 0.5 M sucrose ( Fig. 2a-c ), suggesting that PGRPs do not kill bacteria by rapidly hydrolyzing peptidoglycan and inducing osmotic lysis.
PGRPs do not permeabilize cell membranes
Permeabilization of bacterial cell membranes by PGRPs would explain their rapid and simultaneous inhibition of all biosynthetic reactions that was not prevented by hyperosmotic medium (and thus resembled the effect of membrane-permeabilizing peptides, such as magainin). However PGRPs did not permeabilize bacterial cell membranes over a period of 6 h, despite rapid killing that exceeded 95% in 2-4 h and was not prevented by 0.5 M sucrose (Supplementary Fig. 4) . Thus, the mechanism of bactericidal activity of PGRPs is distinct from the bactericidal activity of antibiotics that inhibit peptidoglycan, protein, RNA or DNA synthesis and is also distinct from membrane-permeabilizing peptides and from enzymes that rapidly hydrolyze the bacterial cell wall.
Bactericidal PGRPs do not hydrolyze peptidoglycan Another possible mechanism of bacterial killing by PGRPs is enzymatic digestion of peptidoglycan. However, bactericidal PGRPs did not hydrolyze insoluble S. aureus or B. subtilis peptidoglycan, uncross-linked soluble polymeric peptidoglycan, synthetic peptidoglycan fragments or heat-killed S. aureus and B. subtilis bacteria (Supplementary Fig. 5 ). Thus, bactericidal PGRPs do not have amidase, carboxypeptidase or any other peptidoglycan-hydrolytic activity. We also excluded the possibility that activation of autolytic enzymes (LytC and LytD) is responsible for PGRP-induced killing of bacteria (Supplementary Results and  Supplementary Figs. 3 and 5) .
PGRPs induce membrane depolarization and [OH] • production
We next considered whether a loss of membrane potential is responsible for inhibition of intracellular biosynthetic reactions and killing of bacteria by PGRPs, because all these reactions require energy from ATP, whose production is largely dependent on ATP synthase driven by the proton gradient maintained by the membrane potential.
Indeed, PGRPs at bactericidal concentrations induced rapid and sustained membrane depolarization in B. subtilis (Fig. 3a) , as measured by flow cytometry with the membrane potential-sensitive fluorescent probe DiBAC 4 (3) (ref. 21) . Membrane depolarization was accompanied by intracellular production of toxic hydroxyl radicals [OH] • , which are part of the bacterial stress response (Fig. 3b) . All bactericidal PGRPs also induced membrane depolarization and high [OH] • production in S. aureus (data not shown).
To determine whether [OH] • production is responsible for PGRPinduced bacterial killing and how [OH] • is generated, we tested the effect of dipyridyl and thiourea on PGRP-induced [OH] • production and bacterial killing. Dipyridyl is a membrane-permeable selective Fe 2+ chelator that inhibits Fenton reaction-mediated [OH] • production, whereas thiourea is a [OH] • scavenger 21 . Both dipyridyl and thiourea significantly inhibited PGRP-induced bacterial killing ( Fig. 3c and a r t i c l e s Supplementary Fig. 6 ). We confirmed effective inhibition of intracellular [OH] • production by dipyridyl with an [OH] •specific fluorescent probe ( Supplementary  Fig. 7a) . These results indicate that [OH] • is generated through the Fenton reaction and is required for PGRP-induced bacterial killing. We then tested the contribution of membrane depolarization to the generation of [OH] • and bacterial killing. The chemical membrane potential decoupler carbonyl cyanide 3-chlorophenylhydrazone (CCCP) induced membrane depolarization and killed bacteria, and the killing was not inhibited by dipyridyl (Fig. 3c) , indicating [OH] • -independent killing by CCCP (further discussed in the Supplementary Results).
PGRPs kill B. subtilis through the CssR-CssS system
We then tested whether the CssR-CssS two-component system in B. subtilis 22 is involved in PGRP-induced membrane depolarization, [OH] • production and bacterial killing, because a functionally homologous CpxA-CpxR two-component system in E. coli detects misfolded proteins in antibiotic-treated bacteria and is responsible for antibiotic-induced membrane depolarization, stress response, [OH] • production and killing 21, 23 .
PGRP-induced membrane depolarization and [OH] • production were significantly reduced in both ∆cssS and ∆cssR mutants compared to isogenic WT B. subtilis (Fig. 3a,b) . Membrane depolarization by CCCP was similar in WT and ∆cssS and ∆cssR mutants, indicating that these mutants do not have an inherent defect in maintaining membrane potential and that the effect of PGRPs is selectively mediated by CssS and CssR. CCCP was bactericidal to both WT and mutant strains at the same concentration that induced membrane depolarization (Fig. 3c) , indicating that this extent of membrane depolarization is sufficient to kill bacteria. [OH] • production induced by gentamicin (Fig. 3b) , an antibiotic that was previously shown to induce [OH] • production in E. coli and S. aureus 21, 23 , was also reduced in ∆cssS and ∆cssR mutants, although the effect was less than that seen on PGRP-induced [OH] • production. These results indicate that both membrane depolarization and [OH] • production induced by PGRPs require the CssR-CssS two-component system.
PGRPs also caused rapid high-level induction of htrA mRNA (HtrA is a membrane-bound protease directly regulated by CssR 22 ) in WT B. subtilis, but not in ∆cssS and ∆cssR mutants (Fig. 3d) . These results indicate that PGRPs induce CssS-and CssR-dependent activation of the CssR-CssS two-component system and activate the regulator (the transcription factor CssR) through the sensor (CssS).
To test whether the CssR-CssS two-component system is responsible for the bactericidal activity of PGRPs, we compared the sensitivity of ∆cssS and ∆cssR mutants and isogenic WT B. subtilis to PGRPs. Whereas WT B. subtilis was readily killed by all four PGRPs (PGLYRP-1, PGLYRP-3, PGLYRP-4 and PGLYRP-3:4), ∆cssS and ∆cssR mutants were ten to 1,000 times less sensitive to killing by all four PGRP proteins (Fig. 4a) . The WT and mutant bacteria had similar growth rates and cell separation in the presence of a control protein (BSA). These results indicate that the CssR-CssS two-component system in B. subtilis is required for bacterial killing by all four PGRP proteins.
To confirm the role of the CssR-CssS two-component system in PGRPmediated killing, we performed complementation experiments. ∆cssS and ∆cssR mutants complemented with cssS-or cssR-expressing pGDL48 plasmids were significantly more sensitive to killing by PGRP proteins than the same mutants transfected with an empty vector or with the same genes inserted in a reverse orientation (Fig. 4b) . The role of the CssR-CssS twocomponent system in bacterial killing is further supported by the lower sensitivity to PGRP-mediated killing of the ∆htrA mutant ( Supplementary  Fig. 8) . These results confirm that the CssR-CssS two-component system is required for the bactericidal effect of PGRP proteins.
PGRPs kill E. coli through the CpxA-CpxR system
To determine whether PGRPs also kill Gram-negative bacteria through protein-sensing two-component systems, we compared the Figure 4 PGRPs kill B. subtilis through the CssR-CssS two-component system. (a) Killing of WT B. subtilis or ∆cssS or ∆cssR mutants incubated with the indicated PGRPs (100 µg ml −1 ) or BSA (control), as measured by colony counts; means of three experiments; the average s.e.m. were 5-19% and are not shown; all mutants had significantly reduced sensitivity to killing by all PGRPs (P < 0.05 versus WT, t test). (b) Complementation of PGRP-induced bacterial killing by cssS and cssR in ∆cssS or ∆cssR mutants transfected with an empty vector (pGDL48) or pGDL48 containing cssS in forward orientation (cssS), cssS in reverse orientation (cssS-Rev), cssR in forward orientation (cssR) or cssR in reverse orientation (cssR-Rev) and incubated with PGLYRP-1 or PGLYRP-3:4 (100 µg ml −1 ) for 4 h; the results are expressed as percentage of surviving bacteria in cssS-or cssR-transfected groups compared to groups transfected with control plasmids (empty vector or reverse sequence); means of three experiments ± s.e.m.; *P < 0.05 versus control plasmid (t test). a r t i c l e s nature medicine VOLUME 17 | NUMBER 6 | JUNE 2011 6 8 1 sensitivity to PGRPs of WT E. coli and its isogenic ∆cpxA and ∆cpxR mutants. E. coli CpxA-CpxR are functional homologs of B. subtilis CssR-CssS; both systems sense extracytoplasmic misfolded proteins and induce membrane depolarization, [OH] • production and stress response 22, 23 . WT E. coli bacteria were readily killed by PGRPs, whereas ∆cpxA and ∆cpxR mutants were significantly more resistant to PGRP-mediated killing (Fig. 5a) .
To confirm the role of the CpxA-CpxR two-component system in PGRP-mediated killing of E. coli, we performed complementation experiments. ∆cpxA and ∆cpxR mutants complemented with cpxAand cpxR-expressing plasmids were significantly more sensitive to killing by PGRP than the same mutants transfected with a control plasmid cpxA(88-489) encoding only the periplasmic loop of CpxA (Fig. 5b) . These results confirm that the CpxA-CpxR two-component system is required for the bactericidal effect of PGRP proteins.
To test whether PGRPs activate the CpxA-CpxR two-component system, we determined whether PGRPs increase the expression of cpxP, which is a stress-response gene directly regulated by CpxR 23, 24 . PGLYRP-1 and PGLYRP-4 (as well as gentamicin, used as a positive control) caused rapid high-level induction of cpxP mRNA in WT E. coli, but not in ∆cpxA and ∆cpxR mutants (Fig. 5c) . These results suggest that PGRPs can activate the regulator (the transcription factor CpxR) through the sensor (CpxA).
Gram-negative bacteria have an outer membrane (which is absent in Gram-positive bacteria) that covers the peptidoglycan layer and is impermeable to most large molecules. To address how PGRPs access the CpxA-CpxR two-component system, we studied localization of PGRPs in E. coli by immunofluorescence and confocal microscopy. We found that the entire E. coli outer membrane uniformly binds PGRPs at all stages of growth ( Fig. 5d) , which is in contrast to the selective localization of PGRPs to cell separation sites in Gram-positive bacteria. Similarly to Gram-positive bacteria, PGRPs do not enter the cytoplasm in E. coli (Fig. 5d) . These results suggest that in Gram-negative bacteria, PGRPs bound to the outer membrane may be sensed by the CpxA-CpxR two-component system, consistent with the ability of E. coli CpxA-CpxR to sense bacterial proteins in the outer membrane 25 .
DISCUSSION
Our results reveal a previously unknown mechanism of bacterial killing by PGRPs. In Gram-positive bacteria, PGRPs enter the cell wall at the site of daughter cell separation during cell division, bind cell wall peptidoglycan in the vicinity of the cell membrane and activate the bacterial CssR-CssS two component system, which triggers bacterial killing by inducing membrane depolarization and [OH] • production in the cytoplasm (Fig. 6) . This process is accompanied by cessation of all major intracellular biosynthetic reactions, probably because of the lack of membrane potential-dependent generation of energy. PGRPs kill Gram-negative bacteria by binding their outer membrane and activating the functionally homologous CpxA-CpxR two-component system. The CssR-CssS and CpxA-CpxR two-component systems are designed to detect and dispose of extracellular misfolded bacterial proteins at the cell membrane-cell wall interface, after these proteins have been exported from the cell 22, 23 , and in Gram-negative bacteria CpxA-CpxR also detects proteins in the outer membrane 25 .
These findings may reveal a general mechanism of bacterial killing relevant to other antibacterial proteins that bind the cell wall or outer membrane but do not enter the cytosol, such as peptidoglycan-binding bactericidal RegIIIγ C-type lectin 1 , galectins 2 , other cell wall-binding lectins and even lysozyme, which has an antibacterial effect that is independent of its peptidoglycan-hydrolyzing activity 26 .
Every bacterial species has many two-component systems, which consist of sensors and regulators and enable bacteria to quickly react to changing environmental conditions. The CssR-CssS and CpxA-CpxR two-component systems of B. subtilis and E. coli are functional homologs, and similar two-component systems are probably present in most, if not all, bacteria 22, 23 . These systems are designed to respond to stress, which induces misfolding of bacterial proteins. a r t i c l e s These misfolded proteins are exported from the cell, detected by these two-component systems and disposed of by associated proteases, such as HtrA in B. subtilis 22 . CssR-CssS responds only to membranetranslocated extracytoplasmic (but not cytoplasmic) misfolded or aggregated proteins, both self and foreign, irrespective of the cause of protein accumulation near the bacterial membrane 27, 28 .
Binding of PGRPs to peptidoglycan induces a structural change in PGRPs that locks peptidoglycan in the protein's binding groove 14 irreversibly and accounts for the persistence of peptidoglycan-bound PGRPs in the cell wall. PGRPs also have a hydrophobic region on the opposite side from the peptidoglycan-binding groove, and thus they may be sensed by CssR-CssS as misfolded proteins (which usually have exposed hydrophobic regions) or aggregated proteins (because misfolded proteins often aggregate, and binding to peptidoglycan induces PGRP aggregation 29 ).
The protein-sensing two-component systems not only trigger removal of the misfolded proteins but also signal into the cell to activate a repair and defense response and induce membrane depolarization and production of toxic [OH] • (ref. 23 ). If stress is sustained or its level is too high, bacteria die. Perhaps such a suicide mechanism evolved to be advantageous to the entire bacterial population, because bacteria that are damaged beyond their repair capabilities promptly die and do not use up scarce resources. We show that mammalian PGRPs exploit this bacterial defense/suicide mechanism to kill bacteria.
Because Gram-positive bacteria have a thick cell wall, to activate the two-component system in the cytoplasmic membrane PGRPs need to traverse the cell wall and bind peptidoglycan near the cell membrane. This is accomplished at the sites of separation of newly formed daughter cells, which in B. subtilis is carried out by LytE, LytF and CwlS 18, 19 . PGRPs co-localize with these enzymes at the cell separation sites, which correspond to the digestion sites of these enzymes observed by electron microscopy 30, 31 (described in the Supplementary Discussion).
Gram-negative bacteria have a different cell wall structure than Grampositive bacteria. They have a thin peptidoglycan layer covered by a lipopolysaccharide (LPS)-containing outer membrane, instead of the thick peptidoglycan layer without an outer membrane found in Grampositive bacteria. Thus, the initial interaction of PGRPs with Gramnegative bacteria is different than that with Gram-positive bacteria and involves the outer membrane. PGRPs have a peptidoglycan-binding groove and additional binding sites outside of this groove that bind other molecules, including LPS 11, 29, [32] [33] [34] . Thus, exogenous LPS inhibits killing of Gram-negative bacteria by PGRPs 11, 12 , similarly to exogenous peptidoglycan, which inhibits killing of Gram-positive bacteria by PGRPs 10 . PGRPs also have a hydrophobic region on the opposite face of the molecule from the peptidoglycan-binding groove that may be involved in binding additional ligands 33 , such as hydrophobic structures in the outer membrane of Gram-negative bacteria or the two-component systems. We have found here that the entire outer membrane in E. coli binds PGRPs, which activates the CpxA-CpxR two-component system and triggers bacterial killing. This killing mechanism is consistent with the previously demonstrated ability of CpxA-CpxR to detect proteins in the outer membrane 25 , although it is not known how outer membrane-bound PGRPs interact with CpxA-CpxR.
In conclusion, although the initial steps of interaction of PGRPs with Gram-positive and Gram-negative bacteria are different, the killing mechanism of PGRPs may be common for all bacteria and depends on the activation of the protein-sensing two-component systems. These two-component systems may become targets for development of new antibacterial therapies, for example by designing peptides modeled on PGRPs that would be bactericidal, nonimmunogenic, less expensive to manufacture than full-length proteins, and active against antibiotic-resistant bacteria (because full-length PGRPs kill multidrug-resistant bacteria 10, 12 ). Further studies will help elucidate the direct mechanism by which PGRPs activate bacterial two-component systems and how targeting these systems can be used to develop new antibacterial therapies.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/.
